A detailed history of China Universal Asset Management Co., Ltd. transactions in Galapagos Nv stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 3,769 shares of GLPG stock, worth $94,564. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,769
Previous 3,769 -0.0%
Holding current value
$94,564
Previous $121,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$32.2 - $42.44 $48,428 - $63,829
1,504 Added 66.4%
3,769 $121,000
Q4 2023

May 21, 2024

SELL
$31.87 - $40.71 $47,932 - $61,227
-1,504 Reduced 39.9%
2,265 $92,000
Q4 2023

Jan 23, 2024

BUY
$31.87 - $40.71 $56,409 - $72,056
1,770 Added 357.58%
2,265 $92,000
Q3 2023

May 21, 2024

BUY
$34.17 - $42.98 $9,055 - $11,389
265 Added 115.22%
495 $17,000
Q3 2023

Oct 30, 2023

BUY
$34.17 - $42.98 $9,055 - $11,389
265 Added 115.22%
495 $17,000
Q2 2023

May 21, 2024

BUY
$37.4 - $44.52 $1,795 - $2,136
48 Added 26.37%
230 $9,000
Q2 2023

Jul 27, 2023

BUY
$37.4 - $44.52 $1,795 - $2,136
48 Added 26.37%
230 $9,000
Q1 2023

May 21, 2024

BUY
$36.5 - $48.0 $1,679 - $2,208
46 Added 33.82%
182 $7,000
Q1 2023

Apr 27, 2023

BUY
$36.5 - $48.0 $1,679 - $2,208
46 Added 33.82%
182 $7,000
Q4 2022

May 21, 2024

SELL
$37.44 - $46.51 $136,019 - $168,970
-3,633 Reduced 96.39%
136 $6,000
Q4 2022

Jan 31, 2023

BUY
$37.44 - $46.51 $149 - $186
4 Added 3.03%
136 $6,000
Q3 2022

Oct 21, 2022

BUY
$42.27 - $57.6 $5,579 - $7,603
132 New
132 $6,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.65B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.